Karachi: IBL HealthCare Limited has announced that its Board of Directors will convene on October 28, 2026, to review the company's financial performance for the quarter ending September 30, 2026. The meeting is set to take place at 15:30 local time in Karachi.

The agenda for the meeting includes the consideration of the quarterly financial results and the declaration of any entitlements, as stipulated by the company's governance protocols. In alignment with regulatory requirements, IBL HealthCare Limited has instituted a closed period from October 22 to October 28, 2026, during which trading of the company's shares by insiders is restricted.

According to information available from the Pakistan Stock Exchange (PSX), such closed periods are mandated under Regulation 5.6.4 to ensure transparency and fairness in the market operations. IBL HealthCare Limited's adherence to these regulations reflects its commitment to maintaining compliance with market standards.

IBL HealthCare Limited operates within the healthcare sector, which is a designated market category, and the upcoming board meeting is expected to provide valuable insights into the company's operational and financial health during the specified quarter.